Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A compound propranolol hydrochloride oral liquid for treating hemangioma in children

A technology of compound propranolol hydrochloride oral liquid and propranolol hydrochloride, which is applied in the field of medicine, can solve the problems of large side effects and poor effect of hemangioma in children, and achieve good bioavailability, small dosage and good taste Effect

Active Publication Date: 2021-07-20
河南百年康鑫药业有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] For above-mentioned situation, in order to overcome the defective of prior art, the object of the present invention is to provide a kind of compound propranolol hydrochloride oral liquid for the treatment of infantile hemangioma, can effectively solve the problem that the side effect of treatment infantile hemangioma is big, and effect is poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A compound propranolol hydrochloride oral liquid for treating hemangioma in children
  • A compound propranolol hydrochloride oral liquid for treating hemangioma in children

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A compound propranolol hydrochloride oral liquid for treating infantile hemangioma, comprising the following raw materials by weight: 200 g of gallinaceous gold, 300 g of hawthorn, 200 g of snakeberry, 250 g of purple pearl leaves, 300 g of salvia miltiorrhiza, 200 g of lotus leaves and propranolium hydrochloride Lol 40g;

[0016] Among them: (1) Put the six raw materials of gallinacea, hawthorn, snakeberry, purple pearl leaf, salvia miltiorrhiza and lotus leaf into the extraction tank, add water until the raw materials are covered, soak at 50°C for 45 minutes, heat to boiling, Decocting twice, adding water 10 times the weight of the Liuwei raw material each time, decocting for 1.5 hours each time, filtering, combining the two filtrates, and concentrating to the first extract with a relative density of 1.25 at 70°C;

[0017] (2) Add ethanol with a volume concentration of 90% to the first extract and mix well, so that the volume of alcohol in the mixture of the first ext...

Embodiment 2

[0021] A compound propranolol hydrochloride oral liquid for treating infantile hemangioma, comprising the following raw materials by weight: 100 g of gallinaceous gold, 200 g of hawthorn, 100 g of snakeberry, 200 g of purple pearl leaves, 200 g of salvia miltiorrhiza, 100 g of lotus leaves and propranolium hydrochloride Lol 30g;

[0022] Among them: (1) Put the six raw materials of gallinarum, hawthorn, snakeberry, purple pearl leaf, salvia miltiorrhiza and lotus leaf into the extraction tank, add water until the raw materials are covered, soak at 45°C for 30 minutes, heat to boiling, Decocting twice, adding water 8 times the weight of the six-flavored raw material each time, decocting for 1 hour each time, filtering, combining the two filtrates, and concentrating to the first extract with a relative density of 1.15 at 65°C;

[0023] (2) Add ethanol with a volume concentration of 80% to the first extract and mix evenly, so that the volume of alcohol in the mixture of the first...

Embodiment 3

[0027] A compound propranolol hydrochloride oral liquid for treating infantile hemangioma, comprising the following raw materials by weight: 300 g of gallinaceous gold, 400 g of hawthorn, 300 g of snakeberry, 300 g of purple pearl leaves, 400 g of salvia miltiorrhiza, 300 g of lotus leaves and propranolium hydrochloride Lol 50g;

[0028] Among them: (1) Put the six raw materials of gallinacea, hawthorn, snakeberry, purple pearl leaf, salvia miltiorrhiza and lotus leaf into the extraction tank, add water until the raw materials are covered, soak at 55°C for 60 minutes, heat to boiling, Decocting twice, each time adding 12 times the weight of the Liuwei raw material medicine, decocting for 2 hours each time, filtering, combining the two filtrates, and concentrating to the first extract with a relative density of 1.35 at 75°C;

[0029](2) Add ethanol with a volume concentration of 95% to the first extract and mix evenly, so that the volume of alcohol in the mixture of the first e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a compound propranolol hydrochloride oral liquid for treating hemangioma in children, which comprises the following raw materials by weight: 100-300g of Gallus gallis, 200-400g of Hawthorn, 100-300g of Snakeberry, and 200-300g of Purple Pearl Leaf , Salvia miltiorrhiza 200-400g, lotus leaf 100-300g and propranolol hydrochloride 30-50g; Compared with the prior art, the present invention has significantly improved quality and effect, high cure rate, low adverse reaction rate, and good mouthfeel , easy to administer to children, small dosage, good bioavailability, and huge social and economic benefits.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a compound propranolol hydrochloride oral liquid for treating infantile hemangioma. Background technique [0002] Infantile hemangiomas (IH) are the most common benign tumors in children. According to literature reports, the incidence of common neonatal hemangiomas is 1.1% to 2.6%, and premature infants can reach 10% or even higher. The rate is three times that of boys. Hemangiomas are embryonic benign neoplastic deformities with biological characteristics of vascular endothelial cell proliferation and natural regression after proliferation. Clinically, infantile hemangiomas are mainly manifested in two completely different stages—— Proliferative phase and regressive phase, IH may not be obvious at birth, but enters the proliferative phase shortly after birth, its initial clinical manifestations are small red plaques or papules, and in the following 6 months to 1 year The tumor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/85A61K9/08A61P35/00A61K31/138A61K35/57
CPCA61K9/0095A61K31/138A61K35/57A61K36/537A61K36/62A61K36/73A61K36/734A61K36/85A61K47/26A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61P35/00A61K2300/00
Inventor 王粉王军政蔡俊安
Owner 河南百年康鑫药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com